What is ipamorelin used for?
Ipamorelin is used in preclinical research as a selective growth hormone secretagogue — protocols study GH-axis pharmacology, isolated GH-release effects without confounding cortisol or prolactin elevation, gastrointestinal-motility research, and combined-research workflows pairing with GHRH analogues.
What the research literature says
Ipamorelin’s central research application is as a selective GH secretagogue — the Raun characterisation work established the compound as the first GH secretagogue with high selectivity for GH release relative to cortisol, prolactin, and ACTH (PMID 9849822). Researchers studying isolated GH-axis effects use ipamorelin specifically to avoid the confounding pituitary-hormone elevations seen with earlier-generation GH secretagogues.
Gastrointestinal-motility research is a secondary application area. The Venkova rodent postoperative-ileus work documented prokinetic activity (PMID 19289567), with extension to gastric-dysmotility models in the Greenwood-Van Meerveld work (PMID 27186127). The Beck human proof-of-concept trial in postoperative-ileus management after bowel-resection surgery (PMID 25331030) extended the framework into the clinical-research context.
Combined-research workflows pairing ipamorelin with the GHRH analogue CJC-1295 No DAC use the dual-receptor pharmacology to drive additive GH release without receptor cross-desensitisation. The Ronin catalog offers this combination as the CJC-1295 + Ipamorelin Blend at fixed 5 + 5 mg loadings.
Why this matters in research context
Ipamorelin’s selectivity for GH release is the central reason research protocols favour it over earlier-generation GH secretagogues. Researchers studying isolated GH-axis effects need clean selectivity to avoid confounding from cortisol or prolactin elevations. The combined-research framework with GHRH analogues extends the application surface into dual-receptor GH-axis pharmacology.
Related compounds
- Ipamorelin 10mg — the compound covered by this answer
- CJC-1295 + Ipamorelin Blend — single-vial combination
Related research questions
- What is the half-life of ipamorelin?
- Does ipamorelin raise cortisol?
- Can CJC-1295 be stacked with ipamorelin?
References
- Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998;139(5):552-561. [PMID 9849822]
- Venkova K et al. Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus. J Pharmacol Exp Ther 2009;329(3):1110-1116. [PMID 19289567]
- Beck DE et al. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis 2014;29(12):1527-1534. [PMID 25331030]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Ipamorelin is sold strictly as a research-grade reagent for laboratory and bench research applications.